Rajni Kannan, BS, MS, RN, ANP-BC, from Laura and Isaac Perlmutter Cancer Center at NYU Langone Medical Center, discusses the adverse events (AEs) commonly seen with combinations of therapies to treat melanoma.
Rajni Kannan
Advertisement
Articles by Rajni Kannan
Advertisement
Latest Updated Articles
Rajni Kannan on Managing AEs From Combination Therapies in MelanomaPublished: April 9th 2016 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Monitoring Later Cytopenias With CAR T-Cell Therapy
2
Frontline Vaccine/Pembro Yields PFS Benefit in Advanced Melanoma
3
FDA Approves Subcutaneous Daratumumab in High-Risk Smoldering Myeloma
4
Durvalumab/FLOT Boosts OS in Resectable Gastric Cancer
5
